173039-10-6
2-(Phosphonomethyl)pentanedioic acid
CAS: 173039-10-6
Molecular Formula: C6H11O7P
173039-10-6 - Names and Identifiers
173039-10-6 - Physico-chemical Properties
| Molecular Formula | C6H11O7P |
| Molar Mass | 226.12 |
| Density | 1.658±0.06 g/cm3(Predicted) |
| Boling Point | 538.8±60.0 °C(Predicted) |
| Appearance | powder |
| Color | white to beige |
| pKa | 2.06±0.10(Predicted) |
| Storage Condition | room temp |
| Use | 2-PMPA is a highly selective glutamate carboxypeptidase II (GCPII) inhibitor with an IC50 value of 300 pM. |
| In vitro study | 2-PMPA is a potent and selective inhibitor of GCPII, an enzyme which catabolizes the abundant neuropeptide N-acetyl-aspartyl-glutamate (NAAG) to N-acetylaspartate (NAA) and glutamate. 2-PMPA demonstrates robust efficacy in numerous animal models of neurological disease. 2-PMPA is a highly polar compound with multiple negative charges causing significant challenges for analysis in biological matrices. 2-PMPA reduces ketamine-induced decrease of cell viability and increase of LDH levels in the mixed cultures but not in the neuronal cultures. |
| In vivo study | Intraperitoneal administration of 100 mg/kg 2-PMPA results in maximum concentration in plasma of 275 μg/mL at 0.25 h. The half-life, area under the curve, apparent clearance, and volume of distribution are 0.64 h, 210 μg×h/mL, 7.93 mL/min/kg, and 0.44 L/kg, respectively. 2-PMPA at 250 mg/kg, in an anesthetized mouse, after an initial rise, produces a rapid decline and a striking attenuation in BOLD signals in gray matter. The signature of 2-PMPA on brain T 2 * signals in gray matter at both 167 and 250 mg/kg includes a significant initial rise lasting several minutes. 2-PMPA has neuroprotective activity in an animal model of stroke and anti-allodynic activity in CCI model. Administration of 2-PMPA (50mg/kg) produces a mean peak concentration of 2-PMPA of 29.66±8.1 μM. This concentration is about 100,000 fold more than is needed for inhibition of NAAG peptidase, and indicates very good penetration to the brain. Administration of 50 mg/kg 2-PMPA (i.p.) produces a continuously increasing extracellular NAAG concentration, which startes directly after application. |
173039-10-6 - Risk and Safety
| RTECS | SA0454800 |
173039-10-6 - Preparation solution concentration reference
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 4.422 ml | 22.112 ml | 44.224 ml |
| 5 mM | 0.884 ml | 4.422 ml | 8.845 ml |
| 10 mM | 0.442 ml | 2.211 ml | 4.422 ml |
| 5 mM | 0.088 ml | 0.442 ml | 0.884 ml |
Last Update：2024-01-02 23:10:35
Supplier List
Spot supply
Product Name: 2-(Phosphonomethyl)pentanedioic acid Visit Supplier Webpage Request for quotationCAS: 173039-10-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Spot supply
Product Name: 2-(Phosphonomethyl)pentanedioic acid Visit Supplier Webpage Request for quotationCAS: 173039-10-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History